MELISSA PARSONS: Open Payments
NPI 1437622875 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 14 payments from 13 companies in 2025. Trend: 2023 $124 · 2024 $181 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 1 | $114 |
| BeOne Medicines USA, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Eisai Inc. | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| ARRAY BIOPHARMA INC | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: COSELA, BRUKINSA, LIBTAYO, Lenvima, Zoladex, ULTOMIRIS, SARCLISA, ENHERTU.
Industry payments across NC — which companies pay providers there.
